These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 17827035

  • 1. Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.
    Teipel SJ, Born C, Ewers M, Bokde AL, Reiser MF, Möller HJ, Hampel H.
    Neuroimage; 2007 Oct 15; 38(1):13-24. PubMed ID: 17827035
    [Abstract] [Full Text] [Related]

  • 2. Relating one-year cognitive change in mild cognitive impairment to baseline MRI features.
    Duchesne S, Caroli A, Geroldi C, Collins DL, Frisoni GB.
    Neuroimage; 2009 Oct 01; 47(4):1363-70. PubMed ID: 19371783
    [Abstract] [Full Text] [Related]

  • 3. Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer disease.
    Urs R, Potter E, Barker W, Appel J, Loewenstein DA, Zhao W, Duara R.
    J Comput Assist Tomogr; 2009 Oct 01; 33(1):73-8. PubMed ID: 19188789
    [Abstract] [Full Text] [Related]

  • 4. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
    Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM.
    Arch Neurol; 2006 May 01; 63(5):693-9. PubMed ID: 16682538
    [Abstract] [Full Text] [Related]

  • 5. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.
    Chételat G, Landeau B, Eustache F, Mézenge F, Viader F, de la Sayette V, Desgranges B, Baron JC.
    Neuroimage; 2005 Oct 01; 27(4):934-46. PubMed ID: 15979341
    [Abstract] [Full Text] [Related]

  • 6. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
    Blasko I, Jellinger K, Kemmler G, Krampla W, Jungwirth S, Wichart I, Tragl KH, Fischer P.
    Neurobiol Aging; 2008 Jan 01; 29(1):1-11. PubMed ID: 17055615
    [Abstract] [Full Text] [Related]

  • 7. Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls.
    Westman E, Simmons A, Zhang Y, Muehlboeck JS, Tunnard C, Liu Y, Collins L, Evans A, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Spenger C, Wahlund LO, AddNeuroMed consortium.
    Neuroimage; 2011 Jan 15; 54(2):1178-87. PubMed ID: 20800095
    [Abstract] [Full Text] [Related]

  • 8. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.
    Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V, Terzi A, Vignolo LA, Di Luca M, Giubbini R, Padovani A, Perani D.
    Neurobiol Aging; 2006 Jan 15; 27(1):24-31. PubMed ID: 16298237
    [Abstract] [Full Text] [Related]

  • 9. Linear measures of temporal lobe atrophy on brain magnetic resonance imaging (MRI) but not visual rating of white matter changes can help discrimination of mild cognitive impairment (MCI) and Alzheimer's disease (AD).
    Saka E, Dogan EA, Topcuoglu MA, Senol U, Balkan S.
    Arch Gerontol Geriatr; 2007 Jan 15; 44(2):141-51. PubMed ID: 16723158
    [Abstract] [Full Text] [Related]

  • 10. Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.
    Hansson O, Buchhave P, Zetterberg H, Blennow K, Minthon L, Warkentin S.
    Neurobiol Aging; 2009 Feb 15; 30(2):165-73. PubMed ID: 17646035
    [Abstract] [Full Text] [Related]

  • 11. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.
    Falini A, Bozzali M, Magnani G, Pero G, Gambini A, Benedetti B, Mossini R, Franceschi M, Comi G, Scotti G, Filippi M.
    Neuroimage; 2005 Jul 15; 26(4):1159-63. PubMed ID: 15878675
    [Abstract] [Full Text] [Related]

  • 12. Whole brain atrophy rate predicts progression from MCI to Alzheimer's disease.
    Spulber G, Niskanen E, MacDonald S, Smilovici O, Chen K, Reiman EM, Jauhiainen AM, Hallikainen M, Tervo S, Wahlund LO, Vanninen R, Kivipelto M, Soininen H.
    Neurobiol Aging; 2010 Sep 15; 31(9):1601-5. PubMed ID: 18829136
    [Abstract] [Full Text] [Related]

  • 13. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
    Wang PN, Liu HC, Lirng JF, Lin KN, Wu ZA.
    Psychiatry Res; 2009 Mar 31; 171(3):221-31. PubMed ID: 19217759
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic utility of novel MRI-based biomarkers for Alzheimer's disease: diffusion tensor imaging and deformation-based morphometry.
    Friese U, Meindl T, Herpertz SC, Reiser MF, Hampel H, Teipel SJ.
    J Alzheimers Dis; 2010 Mar 31; 20(2):477-90. PubMed ID: 20164559
    [Abstract] [Full Text] [Related]

  • 15. Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.
    Höglund K, Hansson O, Buchhave P, Zetterberg H, Lewczuk P, Londos E, Blennow K, Minthon L, Wiltfang J.
    Neurodegener Dis; 2008 Mar 31; 5(5):268-76. PubMed ID: 18309230
    [Abstract] [Full Text] [Related]

  • 16. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.
    Dierckx E, Engelborghs S, De Raedt R, De Deyn PP, Ponjaert-Kristoffersen I.
    Psychol Med; 2007 May 31; 37(5):747-55. PubMed ID: 17164030
    [Abstract] [Full Text] [Related]

  • 17. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
    Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E, Guidi I, Blankenstein MA, Bresolin N, Scarpini E.
    Arch Neurol; 2006 Apr 31; 63(4):538-43. PubMed ID: 16606766
    [Abstract] [Full Text] [Related]

  • 18. A computational method for the estimation of atrophic changes in Alzheimer's disease and mild cognitive impairment.
    Fritzsche KH, von Wangenheim A, Abdala DD, Meinzer HP.
    Comput Med Imaging Graph; 2008 Jun 31; 32(4):294-303. PubMed ID: 18343635
    [Abstract] [Full Text] [Related]

  • 19. Altered spontaneous activity in Alzheimer's disease and mild cognitive impairment revealed by Regional Homogeneity.
    Zhang Z, Liu Y, Jiang T, Zhou B, An N, Dai H, Wang P, Niu Y, Wang L, Zhang X.
    Neuroimage; 2012 Jan 16; 59(2):1429-40. PubMed ID: 21907292
    [Abstract] [Full Text] [Related]

  • 20. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.
    Chételat G, Fouquet M, Kalpouzos G, Denghien I, De la Sayette V, Viader F, Mézenge F, Landeau B, Baron JC, Eustache F, Desgranges B.
    Neuropsychologia; 2008 Jan 16; 46(6):1721-31. PubMed ID: 18289618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.